Escolar Documentos
Profissional Documentos
Cultura Documentos
ary Carcinoid Tum or Cervical Cancer Colorectal Cancer Endom etrial Cancer Esophageal Cancer Gastric Cancer Gastrointestinal Strom al Tum or Head and Neck Cancer Hepatocellular Cancer Kaposi Sarcom a Leukem ia Lung Cancer Lym phom a Melanom a Mesotheliom a Multiple Myelom a Ovarian Cancer Pancreatic Cancer Prostate Cancer Renal Cell Cancer Sarcom a Testicular Cancer Thym om a Myelodysplastic Syndrom e Dosage for Hepatic Dysfunction Dosage for Renal Dysfunction Calculation of Carboplatin Dose
Testicular Cancer
Initial chemotherapy Salvage chemotherapy
Initial chemotherapy
BEP
Regimen 1 (5-day schedule) Bleomycin 30 U or 30 mg iv bolus d1, 8, 15 or d2, 9, 16 Etoposide (VP-16) 100 mg/m2/d iv over 1 h d1-5 Cisplatin (CDDP) 20 mg/m2/d iv over 1 h d1-5 Q3w x 3-4 cycles Culine S et al. Randomized trial comparing bleomycin/etoposide/cisplatin with alternating cisplatin/cyclophosphamide/doxorubicin and vinblastine/bleomycin regimens of chemotherapy for patients with intermediate- and poor-risk metastatic nonseminomatous germ cell tumors: Genito-Urinary Group of the French Federation of Cancer Centers Trial T93MP. J Clin Oncol 2008; 26:421 (link to the article). de Wit R et al. Equivalence of three or four cycles of bleomycin, etoposide, and cisplatin chemotherapy and of 3- or 5-day schedule in goodprognosis germ cell tumor: a randomized study of the European Organization for Research and Treatment of Cancer Genitourinary Tract Cancer Cooperative Group and the Medical Research Council. J Clin Oncol 2001; 19:1629 (link to the article). Nichols CR et al. Randomized comparison of cisplatin and etoposide and either bleomycin or ifosfamide in treatment of advanced disseminated germ cell tumors: an Eastern Cooperative Oncology Group, Southwest Oncology Group, and Cancer and Leukemia Group B study. J Clin Oncol 1998; 16:1287 (link to the article). Williams, SD et al. Treatment of disseminated germ-cell tumors with cisplatin, bleomycin, and either vinblastine or etoposide. N Engl J Med 1987; 316:1435 (link to the article). Regimen 2 (3-day schedule) Bleomycin 30 U or 30 mg iv bolus d1, 8, 15 Etoposide (VP-16) 165 mg/m2/d iv d1-3 Cisplatin (CDDP) 50 mg/m2/d iv d1-2 Q3w x 3-4 cycles de Wit R et al. Equivalence of three or four cycles of bleomycin, etoposide, and cisplatin chemotherapy and of 3- or 5-day schedule in goodprognosis germ cell tumor: a randomized study of the European Organization for Research and Treatment of Cancer Genitourinary Tract Cancer Cooperative Group and the Medical Research Council. J Clin Oncol 2001; 19:1629 (link to the article).
EP
Etoposide (VP-16) 100 mg/m2/d iv over 1 h d1-5 Cisplatin (CDDP) 20 mg/m2/d iv over 1 h d1-5 Q3w x 4 cycles Kondagunta, GV et al. Etoposide and Cisplatin chemotherapy for metastatic good-risk germ cell tumors. J Clin Oncol 2005; 23:9290 (link to the article).
VIP
Etoposide (VP-16) 75 mg/m2/d iv over 1 h d1-5
Etoposide (VP-16) 75 mg/m2/d iv over 1 h d1-5 Ifosfamide 1.2 g/m2/d iv d1-5 Cisplatin (CDDP) 20 mg/m2/d iv over 1 h d1-5 Mesna 120 mg/m2 iv bolus d1 before ifosfamide, followed by 1.2 g/m2/d civi d1-5 Filgrastim (Neupogen) 5 mcg/kg sc qd d7-16 Q3w x 4 cycles Loehrer, PJ Sr et al. Salvage therapy in recurrent germ cell cancer: ifosfamide and cisplatin plus either vinblastine or etoposide. Ann Intern Med 1988; 109:540 (link to the article). McCaffrey, JA et al. Ifosfamide- and cisplatin-containing chemotherapy as first-line salvage therapy in germ cell tumors: response and survival. J Clin Oncol 1997; 15:2559 (link to the article).
TIP
Paclitaxel (Taxol) 250 mg/m2 iv over 24 hrs d1 Ifosfamide 1.5 g/m2/d iv over 1 h d2-5 Cisplatin (CDDP) 25 mg/m2/d iv over 30 min d2-5 Mesna 500 mg/m2 iv before ifosfamide, and at 4 and 8 hrs after ifosfamide daily, d2-5 Filgrastim (Neupogen) 5 mcg/kg sc qd d7-18 Q3w x 4 cycles Kondagunta, GV et al. Combination of paclitaxel, ifosfamide, and cisplatin is an effective second-line therapy for patients with relapsed testicular germ cell tumors. J Clin Oncol 2005; 23:6549 (link to the article).
Cisplatin + Epirubicin
Cisplatin (CDDP) 20 mg/m2/d iv d1-5 Epirubicin 90 mg/m2 iv over 15-30 min d1 Filgrastim (Neupogen) 5 mcg/kg sc qd d7-16, or pegfilgrastim 6 mg sc d7 Q3w x 4 cycles Bedano P et al. Phase II study of cisplatin plus epirubicin salvage chemotherapy in refractory germ cell tumors. J Clin Oncol 2006; 24:5403 (link to the article).
Home
Disclaimer
Contact Us
2006-2008 CHEMOREGIMEN.COM